Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fuze Health›
Products & Services
Diagnostics and Telehealth Services

Fuze Health› offers Diagnostics and Telehealth Services

Product
Currently Offered

Fuze Services delivers integrated diagnostic, screening, genomic, and clinical programs enabling precision medicine and chronic condition management.

Overview
Loading

Fuze Services supports precision medicine, early intervention, and chronic condition management through end-to-end care coordination. Clinical programs include preventive care and screening, functional assessments, post-discharge follow-up, and adherence monitoring supported by in-house experts. Capabilities span scalable diagnostics with CLIA-certified labs and proactive genetic screening to inform personalized care.

With more than 15 million tests completed, 880 thousand abnormal results detected, and over 100 validated biomarkers, Fuze Services has conducted more than 7 million clinical interactions. The platform serves health systems, employers, health plans, and life sciences partners seeking to close care gaps and improve outcomes.

Diagnostics and Telehealth Services - Classification

Industry
  • Healthcare
Tags
  • Digital Health

More from Fuze Health

  • Healthcare Data and Analytics Platform logo

    Healthcare Data and Analytics Platform

  • Digital Pharmacy Fulfillment logo

    Digital Pharmacy Fulfillment

Direct Competitors

  • Everly Well

    Everly Well logo

    Everlywell

  • Colour Health

    Colour Health logo

    Population Health Screening

AttributeDiagnostics and Telehealth ServicesEverlywellPopulation Health Screening
ProviderFuze Healthfuzehealth.com$0 raisedEverly Well$325M raised · Series DColour Health
Founded202420152021
Sells ToEnterpriseConsumers—
Pricing ModelB2BTransactional—
OwnershipPrivatePrivate, Venture Capital—
Diagnostics and Telehealth Services

Provider Fuze Healthfuzehealth.com$0 raised

Founded 2024

Sells To Enterprise

Pricing Model B2B

Ownership Private

Everlywell

Provider Everly Well$325M raised · Series D

Founded 2015

Sells To Consumers

Pricing Model Transactional

Ownership Private, Venture Capital

Population Health Screening

Provider Colour Health

Founded 2021

Sells To —

Pricing Model —

Ownership —